- US
stocks rose on Wednesday on strong earnings and progress on a COVID-19 vaccine. - Nike shares surged, helping to lift the
Dow Jones industrial average , after the company smashed revenue and profit expectations. - Johnson & Johnson said that it would start its phase-three trial of a COVID-19 vaccine candidate and that it planned to enroll up to 60,000 participants.
- Watch major indexes update live here.
Stocks rose on Wednesday as a strong earnings report from Nike and progress on a COVID-19 vaccine helped to boost investor sentiment.
Nike surged — pulling the
Johnson & Johnson said it would begin a phase-three trial of its COVID-19 vaccine candidate. The company plans to enroll up to 60,000 participants in the pivotal trial.
Here's where US indexes stood shortly after the 9:30 a.m. market open on Wednesday:
- S&P 500: 3,317.97, up 0.1%
- Dow Jones industrial average: 27,440.43, up 0.6% (152 points)
- Nasdaq composite: 10,917.56, down 0.4%
Tesla traded lower on Wednesday after its Battery Day event on Tuesday failed to delight investors. The company detailed a $25,000 car it expects to begin selling in three years.
Larry Kudlow, an economic adviser to President Donald Trump, said on Tuesday that a V-shaped recovery wasn't dependent on another round of fiscal stimulus.
"I don't think the V-shaped recovery depends on the package, but I do think a targeted package could be a great help," Kudlow said.
Gold fell as much as 1.4%, to $1,873.23 per ounce, losing its strong support level of $1,900. Treasury yields traded mostly flat, while the US dollar gained ground.
Oil prices climbed. West Texas Intermediate crude rose as much as 1.4%, to $40.15 per barrel. Brent crude, oil's international benchmark, jumped 1%, to $42.15 per barrel, at intraday highs.